chr2-189062865-C-T
Position:
Variant summary
Our verdict is Pathogenic. Variant got 10 ACMG points: 10P and 0B. PM2PP5_Very_Strong
The NM_000393.5(COL5A2):c.1977G>A(p.Pro659Pro) variant causes a splice region, synonymous change involving the alteration of a non-conserved nucleotide. The variant was absent in control chromosomes in GnomAD project. In-silico tool predicts a benign outcome for this variant. 3/3 splice prediction tools predicting alterations to normal splicing. Variant has been reported in ClinVar as Pathogenic (★★).
Frequency
Genomes: not found (cov: 32)
Exomes 𝑓: 0.0 ( 0 hom. )
Failed GnomAD Quality Control
Consequence
COL5A2
NM_000393.5 splice_region, synonymous
NM_000393.5 splice_region, synonymous
Scores
2
Splicing: ADA: 0.9987
2
Clinical Significance
Conservation
PhyloP100: 1.49
Genes affected
COL5A2 (HGNC:2210): (collagen type V alpha 2 chain) This gene encodes an alpha chain for one of the low abundance fibrillar collagens. Fibrillar collagen molecules are trimers that can be composed of one or more types of alpha chains. Type V collagen is found in tissues containing type I collagen and appears to regulate the assembly of heterotypic fibers composed of both type I and type V collagen. This gene product is closely related to type XI collagen and it is possible that the collagen chains of types V and XI constitute a single collagen type with tissue-specific chain combinations. Mutations in this gene are associated with Ehlers-Danlos syndrome, types I and II. [provided by RefSeq, Jul 2008]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Pathogenic. Variant got 10 ACMG points.
PM2
Very rare variant in population databases, with high coverage;
PP5
Variant 2-189062865-C-T is Pathogenic according to our data. Variant chr2-189062865-C-T is described in ClinVar as [Pathogenic]. Clinvar id is 213101.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr2-189062865-C-T is described in Lovd as [Likely_pathogenic].
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
COL5A2 | NM_000393.5 | c.1977G>A | p.Pro659Pro | splice_region_variant, synonymous_variant | 29/54 | ENST00000374866.9 | NP_000384.2 | |
COL5A2 | XM_011510573.4 | c.1839G>A | p.Pro613Pro | splice_region_variant, synonymous_variant | 32/57 | XP_011508875.1 | ||
COL5A2 | XM_047443251.1 | c.1839G>A | p.Pro613Pro | splice_region_variant, synonymous_variant | 34/59 | XP_047299207.1 | ||
COL5A2 | XM_047443252.1 | c.1839G>A | p.Pro613Pro | splice_region_variant, synonymous_variant | 33/58 | XP_047299208.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
COL5A2 | ENST00000374866.9 | c.1977G>A | p.Pro659Pro | splice_region_variant, synonymous_variant | 29/54 | 1 | NM_000393.5 | ENSP00000364000.3 | ||
COL5A2 | ENST00000618828.1 | c.816G>A | p.Pro272Pro | splice_region_variant, synonymous_variant | 22/47 | 5 | ENSP00000482184.1 | |||
COL5A2 | ENST00000470524.2 | n.83G>A | splice_region_variant, non_coding_transcript_exon_variant | 2/8 | 5 |
Frequencies
GnomAD3 genomes Cov.: 32
GnomAD3 genomes
Cov.:
32
GnomAD4 exome Data not reliable, filtered out with message: AC0 AF: 0.00 AC: 0AN: 1461796Hom.: 0 Cov.: 33 AF XY: 0.00 AC XY: 0AN XY: 727200
GnomAD4 exome
Data not reliable, filtered out with message: AC0
AF:
AC:
0
AN:
1461796
Hom.:
Cov.:
33
AF XY:
AC XY:
0
AN XY:
727200
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome Cov.: 32
GnomAD4 genome
Cov.:
32
ClinVar
Significance: Pathogenic
Submissions summary: Pathogenic:2
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
Ehlers-Danlos syndrome, classic type Pathogenic:1
Pathogenic, criteria provided, single submitter | clinical testing | Center for Genomics, Ann and Robert H. Lurie Children's Hospital of Chicago | May 10, 2024 | This variant has been reported in the literature in at least 3 individuals with suspicion or clinical diagnoses of Ehlers-Danlos syndrome, classic type (cEDS), including as de novo in two families (Ritelli 2013 PMID: 23587214; Xu 2019 PMID: 31517854; Ma 2021 PMID: 33834621). It is not present in gnomAD, and has been submitted to ClinVar (Variation ID: 213101). Of note, this is a synonnymous variant that does not change the amino acid at this codon; however, it is located at the last nucleotide of exon 29 and computational splice prediction algorithms predict that it may weaken or abolish the donor splice site. An evaluation of this variant by cDNA sequencing from fibroblast-derived RNA supports these predictions, demonstrating that this variant results in the skipping of exon 29 (Ma 2021 PMID: 33834621). This is not expected to disrupt the reading frame but would remove 6 Gly-X-Y repeats in the encoded triple helical region which may impair the formation of type V collagen heterotrimers (Malfait 2024 PMID: 20301422). In summary, this variant is classified as pathogenic. - |
Ehlers-Danlos syndrome, classic type, 1 Pathogenic:1
Pathogenic, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Jan 18, 2024 | This sequence change affects codon 659 of the COL5A2 mRNA. It is a 'silent' change, meaning that it does not change the encoded amino acid sequence of the COL5A2 protein. RNA analysis indicates that this variant induces altered splicing and likely results in a shortened protein product. This variant is not present in population databases (gnomAD no frequency). This variant has been observed in individual(s) with clinical features of COL5A2-related Ehlers-Danlos syndrome (PMID: 31517854, 33834621). In at least one individual the variant was observed to be de novo. This variant is also known as c.1997G>A. ClinVar contains an entry for this variant (Variation ID: 213101). Variants that disrupt the consensus splice site are a relatively common cause of aberrant splicing (PMID: 17576681, 9536098). Studies have shown that this variant results in skipping of exon 29, but is expected to preserve the integrity of the reading-frame (PMID: 33834621). For these reasons, this variant has been classified as Pathogenic. - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
CADD
Benign
DANN
Benign
Splicing
Name
Calibrated prediction
Score
Prediction
dbscSNV1_ADA
Pathogenic
dbscSNV1_RF
Pathogenic
SpliceAI score (max)
Details are displayed if max score is > 0.2
DS_DL_spliceai
Position offset: 0
Find out detailed SpliceAI scores and Pangolin per-transcript scores at